SB 465·NH·senate

classifying xylazine as a schedule III controlled drug.

FailedFiled Nov 21, 2025

Sponsor: Bill Gannon (R)

Latest Action

Inexpedient to Legislate: MA VV 04/23/2026 HJ 11

Apr 23, 2026

Topics

Get real-time alerts when SB 465 changes status, plus AI-powered summaries and stage predictions.